Microba Life Sciences Limited (FWB:F3Y) Financings
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of fully paid ordinary shares Tranche closed: A$2.02M raised · A$0.04 a share | Oct 28, 2026 | US$1.41M |
| Private placement of fully paid ordinary shares with free attaching unlisted options Announced: about A$4M · A$0.05 a share · Warrants at A$0.0625 for 36 months · Morgans Corporate Limited +1 Dealers: Morgans Corporate Limited (co-lead), Canaccord Genuity (Australia) Limited (co-lead) Insiders: Any shares taken up by Directors under the Placement are subject to approval at the EGM Use of proceeds: Fund the group to cashflow break-even: core diagnostics growth in Australia and UK, new testing product, working capital and offer costs | Jun 12, 2026 | US$2.82M |
| Share purchase plan of fully paid ordinary shares with free attaching unlisted options Announced: up to A$1M · A$0.05 a share · Warrants at A$0.0625 for 36 months Use of proceeds: Working capital | Jun 12, 2026 | US$704,586 |